Xingyan Luo

K313, a novel benzoxazole derivative, exhibits anti‐inflammatory properties via inhibiting GSK3β activity in LPS‐induced RAW264.7 macrophages

Q. Zou, Yantang Wang, Chunfen Mo, 2018, Journal of cellular biochemistry.

BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway

Ping Yang, Y. Liu, Q. Zou, 2013, British journal of pharmacology.

A novel water-soluble benzothiazole derivative BD926 inhibits human activated T cell proliferation by down-regulating the STAT5 activation.

Hua Li, Q. Zou, Zhengliang Chen, 2015, European journal of pharmacology.

PO‐322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity

Si-Yu Wang, Q. Zou, Yantang Wang, 2019, British journal of pharmacology.

Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3

Hua Li, Q. Zou, Yantang Wang, 2019, Journal of Innate Immunity.

Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance

Z. Su, Q. Zou, Yan Zhou, 2016, Journal of immunology research.

Sis-25, a meroditerpenoid derivative with a cyclobutane scaffold, inhibits activated T cell proliferation by targeting GSK3β in vitro and in vivo.

Xiuyin Wu, Pema‐Tenzin Puno, Yantang Wang, 2022, European journal of pharmacology.

A benzoxazole derivative PO‐296 inhibits T lymphocyte proliferation by the JAK3/STAT5 signal pathway

Si-Yu Wang, Q. Zou, Yantang Wang, 2018, Journal of cellular biochemistry.